George A. Werther
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A will and a way to fund medicines for rare diseases: the story of human growth hormone replacement for adults with growth hormone deficiency.
Journal: Internal medicine journal
Published: January 17, 2018
Serum IGFBP-2 levels are associated with reduced insulin sensitivity in obese children.
Journal: Clinical obesity
Published: October 03, 2017
Impaired bone and muscle development in young people treated with antiepileptic drugs.
Journal: Epilepsia
Published: August 11, 2017
Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
Journal: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
Published: October 14, 2016
Response to Comment on Lin et al. Risk Factors for Decline in IQ in Youth With Type 1 Diabetes Over the 12 Years From Diagnosis/Illness Onset. Diabetes Care 2015;38:236-242.
Journal: Diabetes care
Published: July 25, 2015
Best Practice & Research Clinical Endocrinology & Metabolism. Hormone replacement strategies in paediatric and adolescent endocrine disorders. Preface.
Journal: Best practice & research. Clinical endocrinology & metabolism
Published: June 09, 2015
IGFBP-2 - taking the lead in growth, metabolism and cancer.
Journal: Journal of cell communication and signaling
Published: December 09, 2014
IGFBP-2: The dark horse in metabolism and cancer.
Journal: Cytokine & growth factor reviews
Published: December 04, 2014
Intravenous glucagon in a deliberate insulin overdose in an adolescent with type 1 diabetes mellitus.
Journal: Pediatric diabetes
Published: June 16, 2014
IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes.
Journal: International journal of obesity (2005)
Published: May 20, 2014
Last Updated: 09/26/2026